Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases

Class:IdLiteratureReference:198938
_displayNameInhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
_timestamp2007-07-08 13:31:24
author[Person:198937] Yusuf-Makagiansar, H
[Person:198935] Anderson, ME
[Person:198944] Yakovleva, TV
[Person:198949] Murray, JS
[Person:198951] Siahaan, TJ
created[InstanceEdit:198942] de Bono, B, 2007-07-08 13:30:13
journalMed Res Rev
pages146-67
pubMedIdentifier11857637
titleInhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
volume22
year2002
(literatureReference)[Reaction:198941] VCAM1 binds Integrin alpha4beta1 [Homo sapiens]
[Reaction:199050] ICAM1-5 bind Integrin alphaLbeta2 (LFA-1) [Homo sapiens]
[Summation:199468] Integrins play a central role in mediating lymphocyte adhesi...
[Change default viewing format]
No pathways have been reviewed or authored by Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases (198938)